Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel antiandrogens in early development at Yamanouchi

Aug. 17, 1998

New antitumor agents isolated by Sagami

Aug. 17, 1998

Phase II trial of MGI Pharma's anticancer drug has commenced

Aug. 17, 1998

Daiichi team identifies new antitumor taxanes

Aug. 14, 1998

Endorex and UW-Madison will codevelop antitumor compounds

Aug. 14, 1998

Antitumor platinum complexes synthesized at SS Pharmaceutical

Aug. 14, 1998

Sugen and Taiho will jointly develop angiogenesis inhibitors

Aug. 14, 1998

Taisho synthesizes antitumor prostaglandin analogues

Aug. 13, 1998

Yeda, Yissum collaborate in the discovery of tyrosine kinase inhibitors

Aug. 11, 1998

VivoRx discloses bifunctional paclitaxel derivatives

Aug. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...